期刊文献+

血清和肽素水平及肾血流参数对2型糖尿病患者肾功能状况的判断价值 被引量:2

下载PDF
导出
摘要 目的探讨血清和肽素水平及肾血流参数判断2型糖尿病(T2DM)患者肾功能状况的临床价值。方法选择T2DM患者120例,以外源性放射性核素标记物清除率检测结果反映肾小球滤过率(GFR),将患者分为肾功能正常组53例[GFR≥60 m L/(min·1.73 m2)]和肾功能降低组67例[GFR〈60 m L/(min·1.73 m2)]。采用ELISA法检测血清和肽素,肾血流多普勒超声检查记录段间动脉、叶间动脉的收缩期最大血流速度(Vs)、舒张末期最低血流速度(Vd)及阻力指数(RI)。采用受试者工作特征(ROC)曲线分析血清和肽素水平及肾血流参数判断患者肾功能下降的价值。结果肾功能降低组血清和肽素水平及段间动脉、叶间动脉RI均高于肾功能正常组(P均〈0.05),两组段间动脉及叶间动脉Vs、Vd比较差异均无统计学意义(P均〉0.05)。ROC曲线显示,血清和肽素、肾血流参数(段间动脉及叶间动脉RI)及其联合检测诊断T2DM患者肾功能下降的敏感性分别为73.9%、62.2%、94.1%,特异性分别为80.9%、76.3%、70.5%,ROC曲线下面积分别为0.80(95%CI:0.69-0.92)、0.65(95%CI:0.53-0.77)、0.91(95%CI:0.80-0.99)。结论血清和肽素水平及肾血流参数均有助于判断T2DM患者的肾功能,二者联合检测可提高诊断效能。
出处 《山东医药》 CAS 北大核心 2016年第32期66-68,共3页 Shandong Medical Journal
基金 江苏省卫生厅基金资助项目(Z201317)
  • 相关文献

参考文献17

  • 1张路霞,王海燕.从流行病学的角度探讨我国糖尿病肾病的发病趋势及对策[J].中华内科杂志,2010,49(9):804-805. 被引量:112
  • 2Retnakaran R,Cull CA,Thorne KI,et al.Risk factors for renal dysfunction in type 2 diabetes UK Prospective Diabetes Study 74[J].Diabetes,2006,55(6):1832-1839.
  • 3Then C,Kowall B,Lechner A,et al.Plasma copeptin is associated with type 2 diabetes in men but not in women in the populationbased KORA F4 study[J].Acta Diabetol,2015,52(1):103-112.
  • 4Enhorning,S,Wang TJ,Nilsson PM,et al.Plasma copeptin and the risk of diabetes mellitus[J].Circulation,121(19):2102-2108.
  • 5Bardoux P,Bruneval P,Heudes D,et al.Diabetes-induced albuminuria:role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats[J].Nephrol Dial Transplantat,2003,18(9):1755-1763.
  • 6Velho G,Bouby N,Hadjadj S,et al.Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria[J].Diabetes Care,2013,36(11):3639-3645.
  • 7李海霞,张春丽,徐国宾,王学晶,李淑葵,李志艳,张旭初,夏铁安.健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974. 被引量:179
  • 8Swedko PJ,Clark HD,Paramsothy K,et al.Serum creatinine is an inadequate screening test for renal failure in elderly patients[J].Arch Intern Med,2003,163(3):356-360.
  • 9Saleem U,Khaleghi M,Morgenthaler NG,et al.Plasma carboxyterminal provasopressin(copeptin):a novel marker of insulin resistance and metabolic syndrome[J].J Clin Endocrinol Metab,2009,94(7):2558-2564.
  • 10Katan M,Morgenthaler NG,Dixit KC,et al.Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay[J].J Clin Endocrinol Metab,2007,92(7):2640-2643.

二级参考文献31

  • 1杜晓英,李林法,何强,吴东波,陈江华.^(99m)Tc-DTPA肾动态显像检测肾小球滤过率的临床应用评价[J].中华肾脏病杂志,2006,22(5):266-270. 被引量:53
  • 2Chan JC,Malik V,Jia W,et al.Diabetes in Asia:epidemiology,risk factors,and pathophysiology.JAMA,2009,301:2129-2140.
  • 3Zuo L,Wang M,Beijing Hemodialysis Quality Control and Improvement Center.Current status of hemodialysis treatment in Beijing,China.Ethn Dis,2006,16(2 Suppl 2):S2-31-4.
  • 4Lu FH,Yang YC,Wu JS,et al.A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan.Diabet Med,1998,15:564-572.
  • 5Zhang L,Zhang P,Wang F,et al.Prevalenee and factors associated with CKD:a population study from Beijing.Am J Kidney Dis,2008,51:373-384.
  • 6Chen N,Wang W,Huang Y,et al.Community-based study on CKD subjects and the associated risk factors.Nephrol Dial Transplant,2009,24:2117-2123.
  • 7Chen W,Wang H,Dong X,et al.Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China.Nephrol Dial Transplant,2009,24:1205-1212.
  • 8Nelson RG,Pavkov ME,Hanson RL,et al.Changing course of diabetic nephropathy in the Pima Indians.Diabetes Res Clin Pract,2008,82 Suppl 1:S10-14.
  • 9Go AS,Chertow GM,Fan D,et al.Chronic kidney disease and the risks of death,cardiovascular events,and hospitalization.N Engl J Med,2004,351:1296-1305.
  • 10Zhang L,Zuo L,Wang F,et al.Cardiovascular disease in early stages of chronic kidney disease in a chinese population.J Am Soc Nephrol,2006,17:2617-2621.

共引文献295

同被引文献18

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部